Prognostic relevance of AML1/ETO and CBF beta/MYH11 molecular rearrangements in AML patients undergoing hematopoietic stem cell transplantation (HSCT) in first remission (CR1) Artigo Académico uri icon

autores

  • António Augusto Martins de Oliveira Soares Vicente
  • Sanz, GF
  • Lopez, A
  • Barragan, E
  • Martin, G
  • De la Rubia, J
  • Martinez, J
  • Jimenez, C
  • Aksoy-Aksel, A.

data de publicação

  • janeiro 1, 1998

publicada em